RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S058 · decided 2012-05-23
Approval details
- PMA number
- P040024
- Supplement
- S058
- Supplement type
- 30-Day Notice
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2012-04-23
- Decision date
- 2012-05-23
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- TEST LABORATORY FOR ANALYSIS OF A COMPONENT TO BE CHANGED TO AN INTERNAL CHEMICAL QUALITY CONTROL LABORATORY AS OPPOSED TO THE CURRENT CONTRACT TESTING LABORATORY.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.